Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: Direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms

Thyroid

Volumn 23, Issue 5, 2013, Pages 609-616

  Jeong, Shin Young ^a   Kim, Hae Won ^a   Lee, Sang Woo ^a   Ahn, Byeong Cheol ^a   Lee, Jaetae ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; PREVALENCE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SALIVARY GLAND; SALIVARY GLAND FUNCTION; SALIVARY GLAND SCINTISCANNING; SIALOADENITIS; SUBMANDIBULAR GLAND; THYROID SCINTISCANNING; THYROIDECTOMY; XEROSTOMIA;

ADULT; AGED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PREVALENCE; RADIOPHARMACEUTICALS; REPUBLIC OF KOREA; SALIVARY GLANDS; SEVERITY OF ILLNESS INDEX; SIALADENITIS; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND DISEASES; THYROID NEOPLASMS; THYROIDECTOMY; XEROSTOMIA; YOUNG ADULT;

EID: 84880552520     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0106     Document Type: Article

References (23)

1. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720.
2. Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM 1998 Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med 39: 1551-1554.
3. Lin WY, Shen YY, Wang SJ 1996 Short-term hazards of lowdose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 21:780-782.
4. Markitziu A, Lustmann J, Uzieli B, Krausz Y, Chisin R 1993 Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer. Oral Surg Oral Med Oral Pathol 75:318-322.
5. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Tonshoff G, Sippel C, Wolf H, Clausen M, Henze E 1996 Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun 17:681-686.
6. Malpani BL, Samuel AM, Ray S 1996 Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys 35:535-540.
7. Grewal RK, Larson SM, Pentlow CE, Pentlow KS, Gonen M, Qualey R, Natbony L, Tuttle RM 2009 Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation. J Nucl Med 50:1605-1610.
8. Hoelzer S, Steiner D, Bauer R, Reiners C, Farahati J, Hundahl SA, Dudeck J 2000 Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 27:1465-1472.
9. Hyer S, Kong A, Pratt B, Harmer C 2007 Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol) 19:83-86.
10. Solans R, Bosch JA, Galofre P, Porta F, Rosello J, Selva-O'Callagan A, Vilardell M 2001 Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 42:738-743.
11. Henriksen AM, Nossent HC 2007 Quantitative salivary gland scintigraphy can distinguish patients with primary Sjo gren's syndrome during the evaluation of sicca symptoms. Clin Rheumatol 26:1837-1841.
12. Schall GL, Anderson LG, Wolf RO, Herdt JR, Tarpley TM Jr, Cummings NA, Zeiger LS, Talal N 1971 Xerostomia in Sjogren's syndrome. Evaluation by sequential salivary scintigraphy. JAMA 216:2109-2116.
13. Vinagre F, Santos MJ, Prata A, da Silva JC, Santos AI 2009 Assessment of salivary gland function in Sjogren's syndrome: the role of salivary gland scintigraphy. Autoimmun Rev 8:672-676.
14. Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H 1999 Quantitative evaluation of salivary gland scintigraphy in Sjo rgen's syndrome. J Nucl Med 40:64-69.
15. Raza H, Khan AU, Hameed A, Khan A 2006 Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun 27:495-499.
16. Caglar M, Tuncel M, Alpar R 2002 Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med 27:767-771.
17. Silberstein EB 2008 Reducing the incidence of I-131 induced sialadenitis: the role of pilocarpine. J Nucl Med 49:546-549.
18. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ 1991 Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer 67:1539-1543.
19. Dawes C 1987 Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 66:648-653.
20. Ghezzi EM, Lange LA, Ship JA 2000 Determination of variation of stimulated salivaryflowrates. J Dent Res 79:1874-1878.
21. Schneyer LH 1956 Source of resting total mixed saliva of man. J Appl Physiol 9:79.
22. Dixit PS, Ghezzi EM, Wagner-Lange LA, Ship JA 1999 The influence of hypothyroidism and thyroid replace-ment therapy on stimulated parotid flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87: 55-60.
23. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214. Welfare, Republic of Korea